Literature DB >> 15932020

Specific and non-specific natural killer cell responses to viral infection.

Wayne M Yokoyama1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15932020     DOI： 10.1007/0-387-24180-9_8

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN： 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  7 in total

Review 1.  Human genetics of infectious diseases: a unified theory.

Authors:  Jean-Laurent Casanova; Laurent Abel
Journal:  EMBO J       Date:  2007-01-25       Impact factor: 11.598

2.  Human immunodeficiency virus type 1 infection is associated with increased NK cell polyfunctionality and higher levels of KIR3DL1+ NK cells in ugandans carrying the HLA-B Bw4 motif.

Authors:  Michael A Eller; Rebecca N Koehler; Gustavo H Kijak; Leigh Anne Eller; David Guwatudde; Mary A Marovich; Nelson L Michael; Mark S de Souza; Fred Wabwire-Mangen; Merlin L Robb; Jeffrey R Currier; Johan K Sandberg
Journal:  J Virol       Date:  2011-03-16       Impact factor: 5.103

3.  Glycosylation contributes to variability in expression of murine cytomegalovirus m157 and enhances stability of interaction with the NK-cell receptor Ly49H.

Authors:  Natalya V Guseva; Colleen A Fullenkamp; Paul W Naumann; Michael R Shey; Zuhair K Ballas; Jon C D Houtman; Catherine A Forbes; Anthony A Scalzo; Jonathan W Heusel
Journal:  Eur J Immunol       Date:  2010-09       Impact factor: 5.532

4.  Protective and pathologic roles of the immune response to mouse hepatitis virus type 1: implications for severe acute respiratory syndrome.

Authors:  Aaruni Khanolkar; Stacey M Hartwig; Brayton A Haag; David K Meyerholz; Lecia L Epping; Jodie S Haring; Steven M Varga; John T Harty
Journal:  J Virol       Date:  2009-07-01       Impact factor: 5.103

5.  HIV-1 adaptation to NK-cell-mediated immune pressure.

Authors:  Galit Alter; David Heckerman; Arne Schneidewind; Lena Fadda; Carl M Kadie; Jonathan M Carlson; Cesar Oniangue-Ndza; Maureen Martin; Bin Li; Salim I Khakoo; Mary Carrington; Todd M Allen; Marcus Altfeld
Journal:  Nature       Date:  2011-08-03       Impact factor: 49.962

6.  Harnessing soluble NK cell killer receptors for the generation of novel cancer immune therapy.

Authors:  Tal I Arnon; Gal Markel; Ahuva Bar-Ilan; Jacob Hanna; Eyal Fima; Fabrice Benchetrit; Ruth Galili; Adelheid Cerwenka; Daniel Benharroch; Netta Sion-Vardy; Angel Porgador; Ofer Mandelboim
Journal:  PLoS One       Date:  2008-05-14       Impact factor: 3.240

7.  Impact of commonly used transplant immunosuppressive drugs on human NK cell function is dependent upon stimulation condition.

Authors:  Aislin C Meehan; Nicole A Mifsud; Thi H O Nguyen; Bronwyn J Levvey; Greg I Snell; Tom C Kotsimbos; Glen P Westall
Journal:  PLoS One       Date:  2013-03-21       Impact factor: 3.240
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.